We report a case of necrotizing fasciitis caused by Vibrio cholerae O137 in an immunocompromised 49-year-old man. The infection was acquired following a minor traumatic injury and exposure to seawater during the summer of 2009 in Italy. Although highly immunocompromised, the patient survived. The strain was cytotoxic, invasive, and adhesive and contained a fragment of the El Tor-like hemolysin (El Tor hlyA) gene.
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CASE REPORT
In July 2009, an HIV-and hepatitis C virus (HCV)-positive 49-year-old man with chronic liver disease and type 2 diabetes mellitus fell while walking in the sea (Apulian region, Italy) and succumbed to a minor abrasion of his left foot. Four days later, the patient was admitted to a hospital with fever, foot pain, lower-extremity swelling, and erythema on arrival. He was immediately empirically treated with intravenous daptomycin and levofloxacin (500 and 750 mg/day, respectively). Over the following days, hemorrhagic bullous lesions ascending the leg up to the knee and a severe soft tissue necrosis developed and a clinical diagnosis of necrotizing fasciitis was made (Fig. 1) . The patient underwent extensive fasciotomy and soft tissue debridement. Samples of blood, biopsy tissue from the lesion, and feces were taken before treatment with antibiotics. Blood cultures were negative, and pathogenic microorganisms were not detected in feces. The tissue biopsy culture on 5% sheep blood agar and thiosulfate citrate bile salt (TCBS) agar (Oxoid Ltd., Basingstoke, England) yielded only a Gram-negative, oxidase-positive curved bacterium. The isolate was identified as Vibrio cholerae (confidence, 97.8%) by the API ID 32 GN commercial system (bioMérieux, Marcyl'Etoile, France), and the species identification was also confirmed using a standardized biochemical protocol (9) . The isolate did not react with polyvalent anti-O1 and anti-O139 antisera (Denka Seiken Co. Ltd., Tokyo, Japan) and was serotyped as V. cholerae O137 by the National Institute of Infectious Diseases, Tokyo, Japan (16) .
PCR assays were used to detect the presence of toxin-coding genes (10) . These included the cholera toxin (ctx), heat-stable toxin (stn/sto), hemolysin (classical hlyA and biotype El Tor hlyA), toxin-coregulated pilus (classical tcpA and biotype El Tor tcpA), and zonula occludens toxin (zot) genes. Cytotoxicity against Vero cells and adhesive and invasive properties on CaCo-2 and HT29 cells were also investigated (2) . V. cholerae O1 classical biotype ATCC 9459 was used as positive control for PCR amplification of the classical tcpA, classical hlyA, ctxA, and zot genes. The V. cholerae classical biotype and V. cholerae O1 El Tor biotype from the authors' collection were used as positive controls for PCR amplification of the stn/sto and El Tor hlyA and tcpA genes, respectively ( Table 1 ). The strain was cytotoxic, adhesive, and invasive and had El Tor hlyA and classical tcpA genes ( Table 1) .
The susceptibility of the isolate to 14 antimicrobial agents (amoxicillin-clavulanic acid, ampicillin, cefoperazone, cephalexin, cephalothin, ciprofloxacin, colistin, gentamicin, kanamycin, levofloxacin, meropenem, oxolinic acid, tetracycline, trimethoprim-sulfamethoxazole) was determined by the disk diffusion method, according to guidelines of the Clinical and Laboratory Standards Institute (CLSI) (1). The isolate was resistant to cephalexin and colistin. Although the most current antimicrobial recommendation for invasive Vibrio infections includes treatment with doxycycline (5), the parenteral formulation of this antibiotic is unavailable in Italy. For this reason, after the results of antimicrobial susceptibility testing were obtained, treatment was changed to meropenem and levofloxacin (3 g/day and 750 mg/day, respectively).
The patient recovered gradually and was discharged after 50 days of hospitalization.
V. cholerae non-O1 non-O139 strains are globally distributed, common in coastal and estuarine areas, and more abundant during the warmer months (8). Self-limited gastroenteritis or extraintestinal infections occur, the former after the consumption of seafood and the latter after exposure to aquatic environments (8) . Several toxins have been associated with gastrointestinal diseases caused by V. cholerae non-O1 non-O139, including cholera toxin, toxin-coregulated pilus, heat stable enterotoxin, and zonula occludens toxin (4). However, in immunocompromised patients, severe invasive diseases due to this group of microorganisms has been reported where exposure to seawater (particularly in the summertime) occurs (7, 11, 12) . Necrotizing fasciitis is a severe, life-threatening soft tissue infection which usually occurs in individuals with underlying chronic illness, and it has rarely been related to V. cholerae non-O1 non-O139 (7, 12) . Although host factors appear to be more important in the pathogenesis of this group of microorganisms (11), recently reported invasive infections in immunocompetent patients (6, 15) suggest that strain and environmental factors are also of importance. Virulence factors associated with invasive V. cholerae non-O1 non-O139 infections are not understood. A previous study (14) reported bacteremias in the absence of the cholera toxin and suggested hemolytic activity as the putative virulence factor. Moreover, an association between the El Tor-like hemolysin of V. cholerae non-O1 non-O139 and the ability to induce bacteremia in animal models has recently been reported (10) . In agreement with these findings, in this study, a direct correlation between the presence of the El Tor hlyA gene and the cytotoxic, adhesive, and invasive capabilities of V. cholerae O137 and the control strains was found (Table 1) . We therefore suggest that El Tor-like hemolysin may be involved in the pathogenesis of invasive human diseases, even if its exact role remains to be clarified. However, it is also necessary to note that infection by pathogenic strains of V. cholerae non-O1 non-O139 may not always lead to serious disease, due to factors such as host susceptibility and the level of exposure.
To date, cases of invasive infections by this group of microorganisms have been rarely reported in Italy (3, 13) , and to our knowledge, this is the first report of necrotizing fasciitis caused by V. cholerae. A recent study, however, documented the frequent presence of pathogenic V. cholerae non-O1 non-O139 strains in the Italian marine environment in the warmer months (10) , and satellite observations identified that the mean daytime seawater temperature in the area where the patient was exposed ranged between 25.5°C and 26.0°C. These are conditions favoring the proliferation of this group of microorganisms, and clinicians should be alerted to the potential hazard of invasive infections caused by V. cholerae non-O1 non-O139 in Italy.
Previous studies demonstrated that liver diseases, diabetes mellitus, and hematologic malignancy are independent risk factors predisposing patients with invasive V. cholerae non-O1 non-O139 infections, including necrotizing fasciitis, to have a fatal outcome (7, 11, 12) . In the case reported here, despite having the majority of these underlying illnesses, the patient survived. We believe that the strain's susceptibility to a wide range of antibiotics, together with timely and appropriate antibiotic and surgical treatments, contributed to a successful resolution of the infection.
In our opinion, the paucity of cases of necrotizing fasciitis caused by V. cholerae non-O1 non-O139 reported worldwide, associated with the fact that the patient, although highly immunocompromised, survived his infection makes this case unusual.
In conclusion, this case demonstrates that, when the specific risk factors outlined above are present, even a minor skin abrasion can develop into a severe V. cholerae infection. Public education programs on how to limit the risk of exposure to these microorganisms should be considered, in particular, for people in high-risk categories. Further investigations are required to clarify the exact role of the host, environment, and etiologic agent in the pathogenesis of invasive diseases caused by V. cholerae non-O1 non-O139 in healthy and immunocompromised persons. 
